1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Resistant BRCA Wild-Type Ovarian Cancer: new trials by email Literature Review of Resistant BRCA Wild-Type Ovarian Cancer trials Research Report on Resistant BRCA Wild-Type Ovarian Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients Cohort 1: Dose Escalation, Cohort 2: Dose Escalation - Ovarian Cancer, Resistant BRCA Wild-Type Ovarian Cancer | Phase 1 | Terminated | University of Alabama at Birmingham | 1 | 2021-09-01 | 2023-11-21 |
Adnexal Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Neoplasms (1) · Neoplasms by Site (1) · Ovarian Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1)
University of Alabama at Birmingham (1)
United States (1)